Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic intraventricular vancomycin and gentamicin for prevention of external ventricular drain-related infection
IRCT20200502047277N12Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2024
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vancomycin and gentamicin, sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
vancomycingentamicin
Beyond the preview
Go deeper on IRCT20200502047277N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200502047277N12.